Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Maryland
Pharma
AZ tacks on $2B to its investment in US manufacturing, R&D
Citing a rosy view of the U.S. economy’s potential for growth, AstraZeneca is boosting its investment in local manufacturing and R&D by $2 billion.
Fraiser Kansteiner
Nov 12, 2024 10:10am
AZ brings its cell therapy ambitions to MD with $300M investment
Feb 6, 2024 10:05am
Gilead assembles CAR-T manufacturing troika with new FDA nod
Apr 19, 2022 10:45am
FDA scolds Jubilant in the first public Form 483 in months
Aug 23, 2021 11:15am
BioNTech is taking over a Kite Pharma cell therapy plant in MD
Jul 19, 2021 11:01am
Humanigen taps Emergent for fill-finish work on antibody hopeful
Jan 26, 2021 8:10am